Texas State Board of Pharmacy (TSBP)
New Rule 291.30 Adopted on Emergency Basis - Adopted March 20, 2020
Guidance for dispensing drugs in compliance with Emergency Board Rule 291.30
The Texas State Board of Pharmacy is issuing the following guidance to pharmacists when dispensing prescriptions for Chloroquine, Hydroxychloroquine, Mefloquine, or Azithromycin. The rule does not prevent a physician from prescribing one of these drugs for an off-label use. Please note, the intended use for the drug is not required if the practitioner determines the furnishing of this information is not in the best interest of the patient in accordance with Board rule 291.34 (b)(7).
The intent of board rule 291.30 is to prevent the stockpiling of the drugs and to ensure that reasonable quantities are available for ALL patients that require therapy with the drugs, including patients with a COVID-19 diagnosis.
It was not the board’s intent to hinder the use of the drugs on patients that are in need of drug therapy, but rather to prevent unreasonable quantities that would otherwise be representative of hoarding or stockpiling tactics.
In addition, the rule does not apply to a prescription issued for a patient already established on the medication (e.g., prescription to treat rheumatoid arthritis or lupus for already established patients).
Emergency Dispensing of Prescription Medications - Authorized March 19, 2020
Texas Medical Board (TMB)
TMB Waiver for Chronic Pain Patients - UPDATED: May 8, 2020
For additional information regarding TMB's COVID-19 response, please see TMB's website: tmb.state.tx.us/page/coronavirus
Centers for Medicare and Medicaid Services (CMS)
CMS waiver of signature requirement for Part D - March 20, 2020
Drug Enforcement Administration (DEA)
DEA five percent rule exception - April 13, 2020